GlassScriptPhysician profile
Emily F Williams
NPI 1174563191
$1,028.81
in general payments reported to CMS, 2019-2025
24 companies · $69.38 in 2025
The $69.38 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2020: $85.60 · 2021: $195 · 2022: $123 · 2023: $267 · 2024: $147 · 2025: $69.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $484.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $483.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $205.80 | 2020-2025 | Liletta, Lo Loestrin Fe |
| Therapeuticsmd, INC. | $89.07 | 2019-2022 | |
| Agile Therapeutics, INC. | $77.70 | 2021-2024 | Twirla |
| Hologic Sales and Service, LLC | $60.63 | 2019-2024 | Aptima |
| Medtronic, INC. | $56.71 | 2021-2024 | Truclear |
| Astellas Pharma US INC | $41.30 | 2019-2024 | Veozah |
| Mayne Pharma Commercial LLC | $41.21 | 2022-2023 | |
| Boston Scientific Corporation | $39.98 | 2023 | Solyx Sis System |
| Exact Sciences Corporation | $39.66 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Exeltis, USA INC. | $39.12 | 2023-2025 | Slynd |
| Mylan Pharmaceuticals INC. | $38.85 | 2022 | |
| Amag Pharmaceuticals, INC. | $38.54 | 2019-2020 | |
| Avion Pharmaceuticals | $32.13 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $32.09 | 2021-2023 | |
| Novo Nordisk INC | $31.97 | 2020-2024 | Wegovy |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $31.72 | 2019-2020 | |
| Daiichi Sankyo INC. | $19.92 | 2021 | |
| Becton, Dickinson and Company | $19.42 | 2023 | Bd Onclarity |
| Pfizer INC. | $18.54 | 2025 | |
| Meditrina | $18.43 | 2023 | |
| Evofem Biosciences, INC. | $15.45 | 2021 | |
| Ferring Pharmaceuticals INC. | $15.03 | 2019 | |
| Myovant Sciences INC. | $13.49 | 2021 | |
| Lupin INC. | $12.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.